Use IntelliPharm to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
Amina Odidi President, COO, Principal Accounting Officer, Co-Chief Scientific Officer and Director, Ph.D
IntelliPharm Price and Market Media
The median price of IntelliPharm for the period between Sun, Apr 21, 2013 and Tue, May 21, 2013 is 1.97 with a coefficient of variation of 6.38. The daily time series for the period is distributed with a sample standard deviation of 0.13, arithmetic mean of 1.97, and mean deviation of 0.1. The Stock did not receive any noticable media coverage during the period.
IntelliPharmaCeutics International Inc [IPCI] is traded on Nasdaq Capital Markets in USA. It is located in Toronto, ON MW X and employs 39 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 38.85 M. IntelliPharmaCeutics International Inc conducts business under Healthcare sector and is part of Drug Delivery industry. This company has 19.72 M outstanding shares of which 133.14 K shares are currently shorted by private and institutional investors with about 4.7 trading days to cover.
Intellipharmaceutics International Inc. engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs in Canada. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory